Oxytocin, administered intranasally, is being explored as a treatment for socio-communicative challenges in neuropsychiatric conditions like ASD. Although preclinical research and clinical trials have yielded mixed results, ongoing studies aim to better understand its neurophysiological effects.

This project focuses on identifying factors that influence treatment response, such as symptom severity, hormonal levels, and genetic factors. It also includes a bioethical component, using interviews with patients, parents, and healthcare providers to understand their expectations and perceptions of oxytocin treatment, which may impact how the intervention is perceived and evaluated.

This project will be primarily hosted at the KU Leuven with Kaat, and secondments are planned with Linda at AUMC Amsterdam and Lara at the University of Bielefeld. 

You can find out more about Kaat’s research here: Neuromodulation Laboratory